NOS3 and myocardial ischemia: Thiotriazoline, a drug registered in many countries as a methiabolitotropic cardioprotective agent, also exhibits NO scavenger properties, but more moderate effects on eNOS expression in cardiocytes under conditions of myocardial ischemia.